Roivant Sciences Ltd., 10% Owner at Axovant Gene Therapies Ltd. (AXGT), bought 10,666,666 shares at $3.75 ($40.0M) on 2020-02-24, disclosed to the SEC on 2020-02-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.75 | 5,333,333 | $20.0M | 50.0% |
| 2 | $3.75 | 5,333,333 | $20.0M | 50.0% |
| Total | $3.75 avg | 10,666,666 | $40.0M | 100% |
| Filing → |
| IMVT | BUY | 2023-10-04 | $58.0M | — | Filing → |
| IMVT | BUY | 2022-10-07 | $2.5M | — | Filing → |
| IMVT | BUY | 2020-09-04 | $12.5M | — | Filing → |